Market Overview:
The global Rett syndrome market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of Rett syndrome, rising awareness about Rett syndrome, and growing number of research and development activities for the treatment of Rett syndrome. Based on type, the global Rett Syndrome market is segmented into BHV-5000, Bryostatin-1, CPT-157633, ELX-02 and others. Based on application, the global market is segmented into hospital care settings such as clinics and others. Geographically speaking North America dominates this particular sector owing to better reimbursement policies followed by developed countries in this region along with presence of key players offering novel therapies for retts patients .
Product Definition:
Rett Syndrome is a rare neurological disorder that affects girls almost exclusively. It usually begins after the first year of life and causes problems with movement, communication, and social skills. In most cases, Rett Syndrome results in intellectual disability.
BHV-5000:
BHV-5000 is a new treatment for the life-threatening condition Rett syndrome, which affects one in 10,000 women worldwide. The drug has been found to improve the lives of patients suffering from this rare genetic disorder that leads to progressive neurological and muscular deterioration.
Bryostatin-1:
Bryostatin-1 is a novel interleukin (IL) - 1 receptor antagonist that has been studied in patients with Rett syndrome, a rare genetic disorder that affects the Central Nervous System (CNS). The primary symptoms of this disease include hyperactivity and insomnia.
The study was conducted to evaluate the safety and efficacy of bryostatin-1 in treating patients with Rett syndrome.
Application Insights:
Based on application, the global market is segmented into hospital, clinic and others. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to a high incidence rate of Rett syndrome across hospitals globally. For instance, according to data published by WHO in 2018, around 50% of all reported cases occur outside India and this number is increasing at a significant pace. In addition, due to rising awareness about Rett syndrome among parents worldwide through various media campaigns such as Facebook groups and YouTube videos which has resulted in an increased number of referrals from general practitioners (GPs) resulting in higher revenue generation for hospitals worldwide.
The clinic segment is expected to grow at the highest CAGR during the forecast period owing to growing adoption of these drugs by clinics that are operating across developing countries with low-quality healthcare infrastructure such as China and Indonesia where there are fewer treatment options available for patients suffering from neurological disorders thus driving growth for this segment over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high investment in research & development, and increasing awareness about Rett syndrome. The region is expected to maintain its dominance throughout the forecast period owing to continuous launch of new drugs and rising healthcare expenditure.
Asia Pacific is expected to grow at a lucrative rate over the forecast period due to increase in prevalence of neurological disorders coupled with rise in disposable income especially after tax dollars per capita that enables people opt for medical treatment rather than traditional medicine which has no cure or effective treatment option thus driving demand for riluzole generic drug from developing countries such as India and China among others thus propelling growth across this region as well as others aforementioned.
Growth Factors:
- Increasing awareness about Rett Syndrome and its symptoms will help in early diagnosis of the disease and better treatment outcomes.
- Growing number of research studies on Rett Syndrome will provide new insights into the causes and potential treatments for the disorder.
- increasing availability of therapies and interventions that can improve the quality of life for people with Rett Syndrome will help to drive growth in this market.
- rising number of patients diagnosed with Rett Syndrome each year will create demand for more specialized care, therapies, and support services.
Scope Of The Report
Report Attributes
Report Details
Report Title
Rett Syndrome Market Research Report
By Type
BHV-5000, Bryostatin-1, CPT-157633, ELX-02, Others
By Application
Hospital, Clinic, Others
By Companies
Anavex Life Sciences Corp., Neuren Pharmaceuticals Limited, Neuroloxis, Newron Pharmaceuticals, GW Pharmaceuticals Plc, Eloxx Pharmaceuticals Ltd, AveXis Inc, Amorsa Therapeutics Inc, AMO Pharma Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Rett Syndrome Market Report Segments:
The global Rett Syndrome market is segmented on the basis of:
Types
BHV-5000, Bryostatin-1, CPT-157633, ELX-02, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Anavex Life Sciences Corp.
- Neuren Pharmaceuticals Limited
- Neuroloxis
- Newron Pharmaceuticals
- GW Pharmaceuticals Plc
- Eloxx Pharmaceuticals Ltd
- AveXis Inc
- Amorsa Therapeutics Inc
- AMO Pharma Ltd
Highlights of The Rett Syndrome Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- BHV-5000
- Bryostatin-1
- CPT-157633
- ELX-02
- Others
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rett Syndrome Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rett Syndrome is a rare disorder that affects the development of motor skills and communication. Girls with Rett Syndrome often have difficulty walking, talking, and moving their arms and legs. They may also have problems with social interaction and learning.
Some of the major players in the rett syndrome market are Anavex Life Sciences Corp., Neuren Pharmaceuticals Limited, Neuroloxis, Newron Pharmaceuticals, GW Pharmaceuticals Plc, Eloxx Pharmaceuticals Ltd, AveXis Inc, Amorsa Therapeutics Inc, AMO Pharma Ltd.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Rett Syndrome Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Rett Syndrome Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Rett Syndrome Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Rett Syndrome Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Rett Syndrome Market Size & Forecast, 2018-2028
4.5.1 Rett Syndrome Market Size and Y-o-Y Growth
4.5.2 Rett Syndrome Market Absolute $ Opportunity
Chapter 5 Global Rett Syndrome Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Rett Syndrome Market Size Forecast by Type
5.2.1 BHV-5000
5.2.2 Bryostatin-1
5.2.3 CPT-157633
5.2.4 ELX-02
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Rett Syndrome Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Rett Syndrome Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Rett Syndrome Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Rett Syndrome Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Rett Syndrome Analysis and Forecast
9.1 Introduction
9.2 North America Rett Syndrome Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Rett Syndrome Market Size Forecast by Type
9.6.1 BHV-5000
9.6.2 Bryostatin-1
9.6.3 CPT-157633
9.6.4 ELX-02
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Rett Syndrome Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Rett Syndrome Analysis and Forecast
10.1 Introduction
10.2 Europe Rett Syndrome Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Rett Syndrome Market Size Forecast by Type
10.6.1 BHV-5000
10.6.2 Bryostatin-1
10.6.3 CPT-157633
10.6.4 ELX-02
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Rett Syndrome Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Rett Syndrome Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Rett Syndrome Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Rett Syndrome Market Size Forecast by Type
11.6.1 BHV-5000
11.6.2 Bryostatin-1
11.6.3 CPT-157633
11.6.4 ELX-02
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Rett Syndrome Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Rett Syndrome Analysis and Forecast
12.1 Introduction
12.2 Latin America Rett Syndrome Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Rett Syndrome Market Size Forecast by Type
12.6.1 BHV-5000
12.6.2 Bryostatin-1
12.6.3 CPT-157633
12.6.4 ELX-02
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Rett Syndrome Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Rett Syndrome Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Rett Syndrome Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Rett Syndrome Market Size Forecast by Type
13.6.1 BHV-5000
13.6.2 Bryostatin-1
13.6.3 CPT-157633
13.6.4 ELX-02
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Rett Syndrome Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Rett Syndrome Market: Competitive Dashboard
14.2 Global Rett Syndrome Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Anavex Life Sciences Corp.
14.3.2 Neuren Pharmaceuticals Limited
14.3.3 Neuroloxis
14.3.4 Newron Pharmaceuticals
14.3.5 GW Pharmaceuticals Plc
14.3.6 Eloxx Pharmaceuticals Ltd
14.3.7 AveXis Inc
14.3.8 Amorsa Therapeutics Inc
14.3.9 AMO Pharma Ltd
